Streamlining Pulmonology Prior Authorizations with Waystar Clearinghouse Integration

Klivira connects directly with your EMR to automate prior authorizations, leveraging Waystar Clearinghouse for efficient submission of pulmonology PA requests.

Pulmonology practices face unique prior authorization challenges, particularly with high-cost biologics and durable medical equipment. Integrating your EMR with a robust clearinghouse like Waystar is crucial, but manual PA workflows can still bottleneck revenue cycles. Klivira bridges this gap, transforming complex clinical data into actionable, compliant authorization requests.

The Intersection of Pulmonology PA and Waystar Clearinghouse

Pulmonology prior authorizations are intricate, often involving specific clinical criteria for asthma biologics, home oxygen, and IPF antifibrotics. While Waystar excels at facilitating claims and eligibility, the underlying PA request generation and clinical documentation assembly remain a significant operational burden. Klivira enhances this by automating the data extraction and rule application before submission.

Key Pulmonology PA Triggers Requiring Waystar Submission

  • Asthma biologics (e.g., Dupixent, Nucala, Fasenra, Tezspire, Xolair, Cinqair) requiring eosinophil counts and step-therapy adherence.
  • Home oxygen and BiPAP/CPAP devices, often overlapping with sleep medicine.
  • IPF antifibrotics (e.g., Esbriet, Ofev) with specific diagnostic and severity criteria.
  • Lung transplant evaluations and associated immunosuppression regimens.
  • Advanced pulmonary function testing and certain interventional procedures.

Automating Complex Clinical Criteria for Pulmonology PAs

Pulmonology PAs frequently demand adherence to guidelines from bodies like ATS, GOLD for COPD, and GINA for asthma. Klivira's platform incorporates these clinical rules, ensuring that documentation for conditions such as severe asthma biologics, including eosinophil counts and prior controller therapy, is correctly assembled. This reduces common denial reasons like unmet step-therapy requirements or insufficient evidence.

Seamless Data Flow from EMR to Payer via Waystar

Klivira integrates directly with your EMR using standards like SMART on FHIR, extracting necessary clinical data for prior authorizations. This pre-populates X12 278 transactions or payer portal forms. For submission, Klivira can leverage Waystar Clearinghouse as a channel, ensuring that the clinically validated authorization requests reach the appropriate payer efficiently, whether through electronic prior authorization (ePA) or other established routes.

Optimizing Revenue Cycle for Pulmonology Services

Manual prior authorization processes in pulmonology lead to delays, staff burnout, and revenue leakage due to denials. By automating the generation and submission of PAs through Waystar, Klivira helps accelerate approvals for high-cost treatments and devices. This proactive approach minimizes rework, improves cash flow, and allows pulmonology teams to focus on patient care rather than administrative overhead.

Frequently asked questions

How does Klivira handle specific pulmonology documentation requirements like eosinophil counts for asthma biologics?

Klivira's platform is configured to identify and extract specific data points, such as eosinophil counts from lab results within the EMR. For asthma biologics, it ensures that this critical information, along with step-therapy history, is accurately included in the PA request, aligning with payer policies and clinical guidelines like GINA.

Can Klivira integrate with my existing EMR and Waystar Clearinghouse setup?

Yes, Klivira is designed for seamless integration with major EMR systems via standards like SMART on FHIR, and it can utilize Waystar Clearinghouse as a submission conduit. This ensures that your current IT infrastructure is leveraged, minimizing disruption while maximizing automation for pulmonology prior authorizations.

What types of pulmonology services typically require prior authorization through Waystar?

Common pulmonology services requiring prior authorization that can be submitted via Waystar include high-cost asthma biologics (e.g., Dupixent, Nucala), home oxygen therapy, BiPAP/CPAP devices, IPF antifibrotics, and certain advanced diagnostic tests or interventional procedures. Klivira automates the preparation of these diverse requests.

How does Klivira address step-therapy requirements for pulmonology medications?

Klivira's logic incorporates payer-specific step-therapy rules, often critical for asthma and COPD medications. It verifies that required prior therapies, such as high-dose inhaled corticosteroids (ICS-LABA) for asthma biologics, are documented in the patient's record before a PA request is generated, significantly reducing denials.

What is the benefit of automating pulmonology PAs submitted through Waystar?

Automating pulmonology PAs through Klivira and Waystar significantly reduces manual effort, accelerates approval times, and lowers denial rates. This leads to improved revenue cycle efficiency, better patient access to critical treatments, and allows staff to reallocate time from administrative tasks to patient care.

Related coverage

Other pulmonology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo